David Franklin Kong, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3850, Durham, NC 27710
Phone (919) 668-8946
Email address kong0008@dcri.duke.edu

David F. Kong, M.D., A.M., D.M.T., F.A.C.C., F.S.C.A.I. is an Associate Professor of Medicine at Duke University Medical Center and Co-Director of the Cardiovascular Late Phase 3 and Devices Unit at the Duke Clinical Research Institute. An interventional cardiologist at Duke Hospital and a faculty member in the Duke Center for Healthcare Informatics, Dr. Kong specializes in cardiovascular informatics research and integration of evidence from cardiovascular clinical trials. Dr. Kong graduated magna cum laude from HarvardUniversity, where he also received a master’s degree in Organismic and Evolutionary Biology. He received his medical degree from the Johns Hopkins University School of Medicine, and was a resident on the Osler Medical Service at the JohnsHopkinsHospital. He completed fellowships in Cardiovascular Disease and Interventional Cardiovascular Medicine at DukeUniversity before joining the Duke faculty.  Dr. Kong is board certified in internal medicine, cardiology, and interventional cardiology. He is a Certified Diver Medic, Master Diver, and Dive Medical Examiner, and has been elected Fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1995 - 2001
  • Medical Resident, Medicine, Johns Hopkins University, 1993 - 1995
  • M.D., Johns Hopkins University, 1993

Publications

Vora, Amit N., John H. Alexander, Daniel M. Wojdyla, Ronald Aronson, Christopher B. Granger, Harald Darius, Stephan Windecker, et al. “Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.” Circulation 140, no. 23 (December 3, 2019): 1960–63. https://doi.org/10.1161/CIRCULATIONAHA.119.043754.

PMID
31553201
Full Text

Rymer, Jennifer A., Aditya Mandawat, J Dawn Abbott, Mauricio G. Cohen, Justin E. Davies, Ian C. Gilchrist, Sanjit S. Jolly, et al. “Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial.” Am Heart J 218 (December 2019): 84–91. https://doi.org/10.1016/j.ahj.2019.09.014.

PMID
31715434
Full Text

Sullivan, Alexander E., Michael G. Nanna, Sunil V. Rao, Sarah Cantrell, C Michael Gibson, Freek W. A. Verheugt, Eric D. Peterson, et al. “A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.” Catheter Cardiovasc Interv, November 11, 2019. https://doi.org/10.1002/ccd.28535.

PMID
31713326
Full Text

Oka, Hiroshi, Kenji Miki, Iwao Kishita, David F. Kong, and Takahiro Uchida. “A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia.” Pain Med, June 5, 2019. https://doi.org/10.1093/pm/pnz064.

PMID
31165895
Full Text

Fanaroff, Alexander C., Robert Clare, Karen S. Pieper, Kenneth W. Mahaffey, Chiara Melloni, Jennifer B. Green, John H. Alexander, et al. “Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.” Circulation 139, no. 7 (February 12, 2019): 863–73. https://doi.org/10.1161/CIRCULATIONAHA.118.037202.

PMID
30586739
Full Text

Eisenstein, Eric L., Daniel Wojdyla, and David F. Kong. “Estimating Clinical Trial Bleeding Events Using Electronic Health Record Data.” Stud Health Technol Inform 257 (2019): 92–97.

PMID
30741179
Scholars@Duke

Fudim, Marat, Arun Ganesh, Cindy Green, W Schuyler Jones, Michael A. Blazing, Adam D. DeVore, G Michael Felker, et al. “Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF.” Eur Heart J 39, no. 48 (December 21, 2018): 4255–56. https://doi.org/10.1093/eurheartj/ehy682.

PMID
30346508
Full Text

Artzner, Christoph, Melissa Daubert, Wendy Ehieli, David Kong, Joseph Mammarappallil, Konstantin Nikolaou, Daniel T. Boll, and Lynne Koweek. “Impact of computed tomography (CT)-derived fractional flow reserve on reader confidence for interpretation of coronary CT angiography.” Eur J Radiol 108 (November 2018): 242–48. https://doi.org/10.1016/j.ejrad.2018.09.035.

PMID
30396663
Full Text

Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.” Lancet 392, no. 10157 (October 27, 2018): 1519–29. https://doi.org/10.1016/S0140-6736(18)32261-X.

PMID
30291013
Full Text

Saito, Shigeru, Mitchell W. Krucoff, Shigeru Nakamura, Roxana Mehran, Akiko Maehara, Hussein R. Al-Khalidi, Stephen M. Rowland, et al. “Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.” Eur Heart J 39, no. 26 (July 7, 2018): 2460–68. https://doi.org/10.1093/eurheartj/ehy275.

PMID
29931092
Full Text

Pages